SEARCH

SEARCH BY CITATION

References

  • 1
    Ekbom A. The Epidemiology of IBD. A lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis 2004; 10: S324.
  • 2
    Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001; 120: 62235.
  • 3
    Bernstein CN, Leslie WD. Review article: Osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther 2004; 19: 94152.
  • 4
    Vestergaard P. Bone loss associated with gastrointestinal disease: prevalence and pathogenesis. Eur J Gastroenterol Hepatol 2003; 15: 8516.
  • 5
    van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003; 125: 15917.
  • 6
    Trebble TM, Wootton SA, Stroud MA, et al. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status. Aliment Pharmacol Ther 2004; 19: 106371.
  • 7
    Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 1996; 10: 77786.
  • 8
    Silvennoinen J, Lamberg-Allardt C, Karkkainen M, et al. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med 1996; 240: 28592.
  • 9
    Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 2000; 46: S1S8.
  • 10
    Arnaud SB, Goldsmith RS, Lambert PW, et al. 25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 1975; 149: 5702.
  • 11
    Haderslev KV, Jeppesen PB, Sorensen HA, et al. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 2003; 52: 6538.
  • 12
    Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol 2004; 99: 217885.
    Direct Link:
  • 13
    Schoon EJ, Müller MCA, Vermeer C, Schurgers LJ, Brummer R-JM, Stockbrügger RW. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? Gut 2001; 48: 4737.
  • 14
    Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999; 45: 135968.
  • 15
    Silvennoinen JA, Risteli L, Karttunen TJ, Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 1996; 38: 2238.
  • 16
    Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997; 92: 115763.
  • 17
    Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 22833.
  • 18
    Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998; 12: 699705.
  • 19
    Schulte C, Dignass AU, Mann K, Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998; 4: 26875.
  • 20
    Schoon EJ, Geerling BG, Van Dooren IM, et al. Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharmacol Ther 2001; 15: 78392.
  • 21
    Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000; 247: 6370.
  • 22
    Miheller P, Toth M, Molnar E, et al. Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases. Orv Hetil 2001; 142: 155760.
  • 23
    Martin A, Fries W, Luisetto G, et al. Bone density and calcium metabolism in patients with long-standing quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1994; 6: 6116.
  • 24
    McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Clin Nutr 1992; 93: 6977.
  • 25
    Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 55272.
  • 26
    Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 84256.
  • 27
    Faust D, Menge F, Armbruster FP, Lembcke B, Stein J. Increased serum bone sialoprotein concentrations in patients with Crohn's disease. Z Gastroenterol 2003; 41: 2437.
  • 28
    Tajika M, Matsuura A, Nakamura T, et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 2004; 39: 52733.
  • 29
    Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985; 26: 1197203.
  • 30
    Driscoll RH Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982; 83: 12528.
  • 31
    Andreassen H, Rix M, Brot C, Eskildsen P. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 1998; 33: 108793.
  • 32
    Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998; 93: 148390.
    Direct Link:
  • 33
    Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr 1985; 42: 6449.
  • 34
    Freaney R, McBrinn Y, McKenna MJ. Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr 1993; 58: 18791.
  • 35
    Vogelsang H, Klamert M, Resch H, Ferenci P. Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr 1995; 107: 57881.
  • 36
    McCarthy D, Duggan P, O'Brien M, et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 2005; 21: 107383.
  • 37
    Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 1929.
  • 38
    Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 2003; 62: 81321.
  • 39
    Krasinski SD, Russell RM, Furie BC, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr 1985; 41: 63943.
  • 40
    Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K status in a healthy adult population. Am J Clin Nutr 1996; 63: 56673.
  • 41
    Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Washington, DC, USA: National Academy Press, 2001.
  • 42
    Szulc P, Meunier PJ. Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? Lancet 2001; 357: 19956.
  • 43
    Weber P. Vitamin K and bone health. Nutrition 2001; 17: 8808.
  • 44
    Szulc P, Chapuy MC, Meunier PJ, et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 176974.
  • 45
    Rosen HN, Dresner-Pollak R, Moses AC, et al. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 1994; 54: 269.
  • 46
    Dresner-Pollak R, Karmeli F, Eliakim R, et al. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000; 95: 699704.
    Direct Link:
  • 47
    Riggs BL, Melton LJ III, O'Fallon WM. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 1996; 18: S197201.
  • 48
    Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982; 36; 101431.
  • 49
    Silvennoinen JA, Karttunen TJ, Niemelä SE, et al. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995; 37: 716.